Clean Cells is a GMP-licensed Contract Development and Manufacturing Organization providing R&D, production and quality control testing services to the biopharmaceutical industry. Our two-part site located in Western France holds an innovative process development platform, BSL2 and BSL3 GMP manufacturing laboratories and analytical areas to develop bespoke assays and perform GMP testing. Clean Cells is part of the Clean Biologics group and benefits from the additional experience of sister company Naobios, a CDMO with considerable experience in the development and manufacture of virus-based products.
Location: France, Pays de la Loire, Montaigu-Vendée
Employees: 51-200
Founded date: 2000
Investors 2
| Date | Name | Website |
| - | ArchiMed | archimed-g... |
| - | ArchiMed | archimed.g... |
Mentions in press and media 2
| Date | Title | Description |
| 31.07.2026 | iwoca bags £250M debt facility, what H1 2026 tells us about European tech, and Legora acquires 5th startup this year. | This week, we tracked more than 50 tech funding deals worth over €878 million, and over 10 exits, M&A transactions, rumours, and related news stories across Europe. Alongside the week’s top funding rounds, we’ve highlighted key industry... |
| 30.07.2026 | Clean Cells acquires Anaquant to expand biopharma quality control with mass spectrometry expertise | French biopharma quality control services provider Clean Cells today announces its acquisition of French company Anaquant, a specialist in mass-spectrometry-based bioanalysis. Founded in 2020, Clean Cells, a subsidiary of Clean Biologics, o... |